Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

191 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

Eligibility Major Depressive Disorder NCT00785434

- 20/9/21 - 1 formulario, 2 itemgroups, 16 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Efficacy and Safety of Escitalopram Doses up to 50mg in Treatment of MDD; ODM derived from: https://clinicaltrials.gov/show/NCT00785434

Eligibility Major Depression NCT01244724

- 20/9/21 - 1 formulario, 2 itemgroups, 19 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Lexapro for Major Depression in Patients With Epilepsy; ODM derived from: https://clinicaltrials.gov/show/NCT01244724

Eligibility Major Depressive Disorder NCT02263248

- 20/9/21 - 1 formulario, 2 itemgroups, 24 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine; ODM derived from: https://clinicaltrials.gov/show/NCT02263248

Eligibility Major Depressive Disorder NCT00479726

- 20/9/21 - 1 formulario, 2 itemgroups, 11 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS); ODM derived from: https://clinicaltrials.gov/show/NCT00479726

Eligibility Major Depressive Disorder NCT00479414

- 20/9/21 - 1 formulario, 2 itemgroups, 11 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Lilly's Emotional and Physical Symptoms of Depression Study; ODM derived from: https://clinicaltrials.gov/show/NCT00479414

Eligibility Major Depressive Disorder NCT00479453

- 20/9/21 - 1 formulario, 2 itemgroups, 11 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Lilly's Emotional and Physical Symptoms of Depression; ODM derived from: https://clinicaltrials.gov/show/NCT00479453

Eligibility Major Depressive Disorder NCT01423240

- 20/9/21 - 1 formulario, 2 itemgroups, 12 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Major Depressive Disorder With Mixed Features; ODM derived from: https://clinicaltrials.gov/show/NCT01423240

Eligibility Major Depressive Disorder NCT02311725

- 20/9/21 - 1 formulario, 1 itemgroup, 11 items, 1 idioma
Itemgroup: Inclusion Criteria
Storytelling Video Intervention for Depressed Primary Care Patients - Pilot Trial; ODM derived from: https://clinicaltrials.gov/show/NCT02311725 Principal Investigator: Lisa Uebelacker, PhD Butler Hospital/Brown University and Brandon Gaudiano, PhD Butler Hospital/Brown University

Eligibility Depressive Disorder, Major NCT00223288

- 17/9/21 - 1 formulario, 2 itemgroups, 12 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Impact of Caregiver Depression on Asthma in the Child; ODM derived from: https://clinicaltrials.gov/show/NCT00223288

Eligibility Depressive Disorder, Major NCT00150839

- 17/9/21 - 1 formulario, 2 itemgroups, 14 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Hippocampal Volume in Young Patients With Major Depression Before and After Combined Antidepressive Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00150839

DELCODE: DZNE – Longitudinal Cognitive Impairment and Dementia Study - Major Depression Episode (MDE) Follow-up (Major Depression Episode (MDE) Follow-up)

- 9/4/20 - 1 formulario, 3 itemgroups, 23 items, 1 idioma
Itemgroups: Administrative Data, Major Depression Episode (MDE), Major Depression Episode (MDE) since last visit
DELCODE is conducted by DZNE, the German Center for Neurodegenerative Diseases within the Helmholtz Association. The following information was taken from https://www.dzne.de/en/research/studies/clinical-studies/delcode/. Background and aims: One of the important aims of research into Alzheimer's is to find ways of detecting the disease early – if at all possible, as soon as the first minor symptoms appear, or even before any symptoms at all have appeared. Such detection capabilities are the necessary basis for development of therapies that can be applied at such early stages in the disease. Recent research indicates that such therapies could be more effective than therapies initiated during the disease's later stages. Over a period of several years, the DELCODE study is studying persons in early stages of the disease, along with various risk groups. The research is aimed at the development of procedures for characterizing early stages of the disease, at improving prediction of the course of the disease and at identifying new markers for early diagnosis of Alzheimer's-related dementia. Overview: DELCODE is set up to run for an initial period of three years, and to include a total of 1,000 study participants, who will be examined on a yearly basis. The group of participants will include persons with no complaints (healthy control subjects), patients with slight memory impairment or mild dementia and first-degree relatives of patients with diagnosed Alzheimer's disease. The minimum age for participants is 60. Course of the study: The examinations in the framework of the study will include a comprehensive interview carried out by a study investigator, a detailed neuropsychological examination (testing of memory functions and other areas of cognitive performance), a blood test and a cranial MRI scan. Optionally, subject to the study participant's consent in each case, a lumbar puncture (collection of cerebrospinal fluid) will be carried out." For more information (e.g. principle investigator and study coordination), please visit the above link or https://www.dzne.de. This document contains the Major Depression Episode (MDE) Follow-up form. It has to be filled in for follow-up visits. For use of this questionnaire no licence is required.

DELCODE: DZNE – Longitudinal Cognitive Impairment and Dementia Study - Major Depression Episode (MDE) Baseline (Major Depression Episode (MDE) Baseline)

- 9/4/20 - 1 formulario, 4 itemgroups, 26 items, 1 idioma
Itemgroups: Administrative Data, Major Depression Episode (MDE), Major Depression Episode (MDE) lifetime, MDE - Lifetime
DELCODE is conducted by DZNE, the German Center for Neurodegenerative Diseases within the Helmholtz Association. The following information was taken from https://www.dzne.de/en/research/studies/clinical-studies/delcode/. Background and aims: One of the important aims of research into Alzheimer's is to find ways of detecting the disease early – if at all possible, as soon as the first minor symptoms appear, or even before any symptoms at all have appeared. Such detection capabilities are the necessary basis for development of therapies that can be applied at such early stages in the disease. Recent research indicates that such therapies could be more effective than therapies initiated during the disease's later stages. Over a period of several years, the DELCODE study is studying persons in early stages of the disease, along with various risk groups. The research is aimed at the development of procedures for characterizing early stages of the disease, at improving prediction of the course of the disease and at identifying new markers for early diagnosis of Alzheimer's-related dementia. Overview: DELCODE is set up to run for an initial period of three years, and to include a total of 1,000 study participants, who will be examined on a yearly basis. The group of participants will include persons with no complaints (healthy control subjects), patients with slight memory impairment or mild dementia and first-degree relatives of patients with diagnosed Alzheimer's disease. The minimum age for participants is 60. Course of the study: The examinations in the framework of the study will include a comprehensive interview carried out by a study investigator, a detailed neuropsychological examination (testing of memory functions and other areas of cognitive performance), a blood test and a cranial MRI scan. Optionally, subject to the study participant's consent in each case, a lumbar puncture (collection of cerebrospinal fluid) will be carried out." For more information (e.g. principle investigator and study coordination), please visit the above link or https://www.dzne.de. This document contains the Major Depression Episode (MDE) Baseline form. It has to be filled in for Baseline. For use of this questionnaire no licence is required.

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial